Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Maternal hepatitis C virus infection and three adverse maternal outcomes in the United States.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
- Publication Information:
Original Publication: San Francisco, CA : Public Library of Science
- Subject Terms:
- Abstract:
Background: Hepatitis Virus C (HCV) infection rates have trended upwards among pregnant people in the USA since 2009. Existing evidence about HCV infections and maternal outcomes is limited; therefore, we used birth certificate data to investigate the association between HCV infection and maternal health outcomes.
Methods: We used the 2017 US birth certificate dataset (a cross-section of 1.4 million birth records) to assess the association between prevalent HCV infection and gestational diabetes, gestational hypertension, and eclampsia. Potential confounding variables included prenatal care, age, education, smoking, presence of sexually transmitted infections (STIs), body mass index (BMI), and weight gain during pregnancy. We restricted our analysis to only women with a first singleton pregnancy. Odds ratios were estimated by logistic regression models and separate models were tested for white and Black women.
Results: Only 0.31% of the women in our sample were infected with HCV (n = 4412). In an unadjusted model, we observed a modest significant protective association between HCV infection and gestational diabetes (Odds ratio [OR]: 0.83; 95% CI: 0.76-0.96); but this was attenuated with adjustment for confounding variables (Adjusted odds ratio [AOR]: 0.88; 95% CI: 0.76, 1.02). There was no association between HCV and gestational hypertension (AOR: 1.03; 95% CI: 0.91, 1.16) or eclampsia (AOR: 1.15; 95% CI: 0.69, 1.93). Results from the race stratified models were similar to the non-stratified summary models.
Conclusion: We observed no statistically significant associations between maternal HCV infection with maternal health outcomes. Although, our analysis did indicate that HCV may lower the risk of gestational diabetes, this may be attributable to confounding. Studies utilizing more accurately measured HCV infection including those collecting type and timing of testing, and timing of infection are warranted to ensure HCV does not adversely impact maternal and/or fetal health. Particularly in the absence of recommended therapy for HCV during pregnancy.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright: © 2023 Hood et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- References:
J Clin Invest. 2020 Feb 3;130(2):748-753. (PMID: 31904583)
Obstet Gynecol. 2019 Feb;133(2):289-300. (PMID: 30633134)
Matern Child Health J. 2020 Feb;24(2):177-185. (PMID: 31834607)
Obstet Gynecol. 2020 Feb;135(2):387-395. (PMID: 31923064)
Can J Gastroenterol Hepatol. 2019 Jun 2;2019:8654741. (PMID: 31275902)
MMWR Morb Mortal Wkly Rep. 2019 Oct 04;68(39):833-838. (PMID: 31581170)
Am J Obstet Gynecol. 2008 Jul;199(1):38.e1-9. (PMID: 18486089)
Eur J Obstet Gynecol Reprod Biol. 2018 May;224:125-130. (PMID: 29597101)
Hosp Pediatr. 2019 Aug;9(8):639-642. (PMID: 31292149)
World J Gastroenterol. 2007 May 7;13(17):2436-41. (PMID: 17552026)
N Engl J Med. 1999 Aug 19;341(8):556-62. (PMID: 10451460)
J Reprod Med. 2003 Apr;48(4):217-24. (PMID: 12746982)
Clin Infect Dis. 2012 Jul;55 Suppl 1:S10-5. (PMID: 22715208)
MMWR Morb Mortal Wkly Rep. 2017 May 12;66(18):470-473. (PMID: 28493860)
Clin Infect Dis. 2016 Feb 1;62(3):298-304. (PMID: 26628566)
World J Gastroenterol. 2017 Mar 7;23(9):1697-1711. (PMID: 28321170)
Epidemiology. 1999 Jan;10(1):37-48. (PMID: 9888278)
Arch Intern Med. 2011 Sep 26;171(17):1528-40. (PMID: 21709184)
Health Aff (Millwood). 2018 Mar;37(3):421-428. (PMID: 29505365)
MMWR Morb Mortal Wkly Rep. 2019 May 10;68(18):423-429. (PMID: 31071074)
Health Equity. 2018 Sep 24;2(1):249-259. (PMID: 30283874)
Liver Int. 2011 Sep;31(8):1163-70. (PMID: 21745298)
Hepatol Commun. 2019 Jul 11;3(9):1183-1190. (PMID: 31497740)
Gastroenterol Clin North Am. 2015 Dec;44(4):717-34. (PMID: 26600216)
J Viral Hepat. 2011 Jul;18(7):e394-8. (PMID: 21692952)
MMWR Recomm Rep. 2020 Apr 10;69(2):1-17. (PMID: 32271723)
Med Care. 2017 Oct;55(10):886-892. (PMID: 28906314)
J Viral Hepat. 2015 Dec;22(12):1033-42. (PMID: 26081198)
- Publication Date:
Date Created: 20231018 Date Completed: 20231023 Latest Revision: 20231023
- Publication Date:
20240829
- Accession Number:
PMC10584094
- Accession Number:
10.1371/journal.pone.0291994
- Accession Number:
37851609
No Comments.